Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Edouard Kling has worked on the following 21 EPO patent applications which have been published in the last five years:

EP13767179

ARYL ETHER-BASE KINASE INHIBITORS

IPC classification:
A61K 31/444, A61P 25/00, C07D 491/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
GRANT OF PATENT INTENDED
EP14815171

4,4'-BIPHENYLDIYL-BIS-(1 H-IMIDAZOLYL) DERIVATIVES AS HEPATITIS HCV INHIBITORS

IPC classification:
A61K 31/4025, A61P 31/12, C07D 405/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15747721

PYRIMIDINONES AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/4162, A61P 7/02, C07D 471/18
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15705427

MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES

IPC classification:
A61K 31/439, A61P 9/10, C07D 471/18, C07D 487/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP14704047

ARYL LACTAM KINASE INHIBITORS

IPC classification:
A61K 31/4375, A61P 25/02, A61P 25/16, A61P 25/28, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15705428

MACROCYCLES WITH AROMATIC P2' GROUPS AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/529, A61P 7/00, C07D 471/08, C07D 487/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15705860

MACROCYCLES WITH HETROCYCLIC P2' GROUPS AS FACTOR XIA INHIBITORS

IPC classification:
A61K 31/529, A61P 7/00, C07D 471/08, C07D 487/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15734515

HEPATITIS C VIRUS INHIBITORS

IPC classification:
C07K 5/062, C07K 5/083
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15742478

SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK

IPC classification:
A61K 31/502, A61P 9/00, C07D 237/32, C07D 403/08, C07D 403/12, C07D 413/14, C07D 417/12, C07D 417/14, C07D 471/04, C07D 513/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15747706

HETEROCYCLIC KINASE INHIBITORS

IPC classification:
C07D 401/04, C07D 403/04, C07D 413/04, C07D 417/04, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15756322

TIED-BACK BENZAMIDE DERIVATIVES AS POTENT ROCK INHIBITORS

IPC classification:
A61K 31/4155, A61K 31/437, C07D 401/14, C07D 403/12, C07D 405/14, C07D 413/14
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
EXAMINATION REQUESTED
EP15763756

DIAMIDE MACROCYCLES THAT ARE FXIA INHIBITORS

IPC classification:
A61K 31/395, A61P 7/02, C07D 401/06, C07D 401/12, C07D 403/06, C07D 403/12, C07D 409/12
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15790314

CYCLOBUTANE CONTAINING CARBOXYLIC ACID GPR120 MODULATORS

IPC classification:
A61K 31/192, A61P 3/06, A61P 3/10, A61P 9/10, C07C 59/72, C07C 59/90, C07C 62/34, C07D 213/643, C07D 213/70
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15766344

CYCLOPROPANECARBOXYLIC ACID GPR120 MODULATORS

IPC classification:
A61K 31/185, A61K 31/33, A61P 3/10, C07C 62/34, C07D 207/323, C07D 231/12, C07D 277/593, C07D 307/82
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP14776949

MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80 (B7-1)/PD-LI PROTEIN/PROTEIN INTERACTIONS

IPC classification:
A61K 38/10, C07K 7/08, G01N 33/574
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15763798

PHENYL-(AZA)CYCLOALKYL CARBOXYLIC ACID GPR120 MODULATORS

IPC classification:
A61K 31/192, A61K 31/44, A61K 31/445, A61K 31/55, A61P 3/00, C07C 59/64, C07C 59/68, C07C 62/34, C07D 205/04, C07D 207/12, C07D 211/14, C07D 211/42, C07D 211/46, C07D 213/65, C07D 223/08
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15778153

QUINAZOLINE-BASED KINASE INHIBITORS

IPC classification:
A61K 31/517, A61P 25/00, A61P 25/16, A61P 25/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made
EP15781564

IMMUNOMODULATORS

IPC classification:
A61K 38/12, C07K 7/52, C07K 7/56, G01N 33/68
Applicant:
Bristol-Myers Squibb Company
Agent:
Edouard Kling, Swords Laboratories
Status:
Request for examination was made

Please Sign in to use this feature